Clinical Trial Update: Study of ACC-1898 in Adult Participants With Advanced Solid Tumors [Phase 1]

View source ↗

Summary

Phase 1 study update for ACC-1898 in adults with advanced solid tumors; the trial is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Differentiated Thyroid Carcinoma
• Gallbladder Cancer
• Gastric Adenocarcinoma
• Gastroesophageal Junction Adenocarcinoma
• Hepatocellular Carcinoma
• Medullary Thyroid Carcinoma
• Melanoma
• Renal Cell Carcinoma

Drugs mentioned

• ACC-1898

Snippet

Sponsor: AccSalus Biosciences, Inc. | Conditions: Hepatocellular Carcinoma, Renal Cell Carcinoma | Phase 1 | Status: NOT_YET_RECRUITING